Renowned Neuroscientist Dr. Mary Phillips Maps Bipolar Disorder Circuitry to Predict Symptoms Before They Surface

Renowned neuroscientist Mary L. Phillips uses neural network mapping to identify bipolar disorder biomarkers before symptoms appear, advancing precision psychiatry.

By: AXL Media

Published: Mar 17, 2026, 8:40 AM EDT

Source: Information for this report was sourced from Genomic Press

The Biological Foundations of Mental Health

The trajectory of modern psychiatry has been significantly altered by the conviction that the brain’s neural architecture dictates behavior with the same precision as any other physical organ. Dr. Mary L. Phillips, newly elected to the National Academy of Medicine, has spent her career championing the idea that psychiatric conditions are rooted in specific, measurable neural networks. This journey into biological psychiatry began not with human patients, but with a zoological study of the sea slug, Aplysia, whose simple neural framework provided a Rosetta Stone for understanding how complex behaviors emerge from basic circuitry. According to Dr. Phillips, this early exposure to neuroscience provided the essential realization that understanding the network is the key to understanding the individual.

Mapping the Geography of Bipolar Risk

The central mission of Dr. Phillips’s current research is to identify abnormalities in the prefrontal-striatal-limbic circuitry that serve as early warning signs for bipolar disorder. By tracking the development of these large-scale neural networks from infancy through young adulthood, her laboratory at the University of Pittsburgh can map patterns of emotional reactivity before they escalate into clinical illness. This longitudinal approach allows for a "pre-symptomatic" understanding of the disorder, effectively reading the neural circuitry before the illness has a chance to define the patient's life. This work is critical because, once a disorder like bipolar is fully established, the clinical options often become far more limited and reactive rather than proactive.

A Transatlantic Leap into Interventional Psychiatry

The transition from the clinical environment of London’s Maudsley Hospital to the research-heavy landscape of Pittsburgh marked a pivotal shift in Dr. Phillips’s ability to scale her findings. Under the mentorship of eminent figures like Professor David Kupfer, she established a robust research infrastructure that now encompasses three specialized centers focusing on interventional, metabolic, and translational neuroscience. These centers are currently collaborating with biotechnology firms to investigate the biological mechanisms behind novel neuromodulation and metabolic treatments. The goal is to optimize these emerging therapies at an individual level, moving...